Dr Robert Paul Lemme, DO in Malmstrom Afb, MT - General Practice

Dr Robert Paul Lemme, DO is a General Practice physician based in Malmstrom Afb, Montana. Dr Robert Paul Lemme is licensed to practice in Nebraska (license number 2661) and his current practice location is 7300 N Perimeter Rd, Malmstrom Afb, Montana. He can be reached at his office (for appointments etc.) via phone at (406) 731-6626.

NPI number for Dr Robert Paul Lemme is 1063092336 and his current mailing address is 7300 N Perimeter Rd, Malmstrom Afb, Montana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1063092336.

Contact Information

	Dr Robert Paul Lemme, DO
	7300 N Perimeter Rd, Malmstrom Afb, MT 59402-6701
	(406) 731-6626
	Not Available

Physician's Profile

Full Name	Dr Robert Paul Lemme
Gender	Male
Speciality	General Practice
Location	7300 N Perimeter Rd, Malmstrom Afb, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1063092336
Provider Enumeration Date: 04/12/2021
Last Update Date: 09/26/2022

Medical Identifiers

Medical identifiers for Dr Robert Paul Lemme such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063092336	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	2661 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Robert Paul Lemme is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Robert Paul Lemme, DO 7300 N Perimeter Rd, Malmstrom Afb, MT 59402-6701 Ph: (801) 372-0900	Dr Robert Paul Lemme, DO 7300 N Perimeter Rd, Malmstrom Afb, MT 59402-6701 Ph: (406) 731-6626

News Archive

Study examines effects of AEDs on nicotine metabolite levels in smokers

UMDNJ-Robert Wood Johnson Medical School researchers have determined that carbamazepine and oxycarbamazepine, medications commonly used to treat neurologic and psychiatric conditions, increase nicotine metabolism in smokers. As nicotine metabolism increases, cravings for nicotine return more quickly which could lead to more frequent cigarette consumption among individuals who also take these medications.

Acceleron Pharma commences Phase 2 clinical trial of ACE-031 protein therapeutic in DMD patients

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the initiation of a Phase 2 clinical trial with ACE-031 in patients with Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease. ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting signaling of a cell surface receptor called the activin receptor type IIB (ActRIIB).

U.N., IMF release reports on how global economic crisis 'dealt critical blow' to aid for poor countries

Ahead of next week's U.N. Millennium Development Summit, "[t]he United Nations and International Monetary Fund said Thursday that the global financial crisis has dealt a critical blow to aid for poor countries with billions of dollars needed to meet shortages," Agence France-Presse reports. "Both institutions said that the world must return to sustainable growth to hope to reach global poverty and health targets" (Donnet, 9/16).

Research!America to honor authors of study on EMR and infant mortality with Garfield award

The authors of a landmark study on the use of electronic medical records (EMRs) to reduce infant mortality will receive the 2012 Garfield Economic Impact Award. Amalia R. Miller, PhD, and Catherine E. Tucker, PhD, are being honored for their paper, "Can Health Care Information Technology Save Babies?"

VA develops FATE survey to access treatment quality at the end of patients' lives

Though there have been significant improvements in the treatment of head and neck cancer, there is still a lack of data on the experience of end of life care for head and neck cancer patients, according to a new study published in the May 2011 issue of Otolaryngology-Head and Neck Surgery.

Dr Robert Paul Lemme, DO - General Practice in Malmstrom Afb, MT